Loading...

ATAI ATAI BECKLEY NV US FDA Inspections 8-K Filing

T BC

T

ATAI BECKLEY NV

(ATAI)

2025 8-K

Registration Update

Financial Results Release

Share Resale Filing

Acquisition Completion

Shareholder Meeting Results

Share Purchase Amendment

Public Offering Closure

Share Offering Details

FDA Breakthrough Designation

Acquisition Update

Acquisition Update

Positive Trial Results

Quarterly Results Report

Equity Offerings

Asset Acquisitions

Financial Statements

Debt Restructuring

Appointments, Resignations,...

Bitcoin Investment

Financial Results

Public Offering

Board Resignation

Management Changes

Financial Results

Acquisition Completed

Loan Agreement Update

Financial Results

Investor Presentation

Resignation and Shareholder...

Financial Results and Manag...

Financial Results Announcement

Management Changes

Acquisition of Beckley Psyt...

Consultancy Agreement with ...

Investment Announcement

Entry Into a Material Defin...

Earnings Reports

Appointment of Interim CFO

Management Transition

Departure and Appointment o...

Financial Results Announcement

Loan Agreement Amendment

Annual General Meeting

Financial Results Announcement

Financial Results Announcement

External Links:

On September 23, 2025, ATAI Life Sciences N.V. reported positive Phase 2a results for BPL-003, showing a significant 19.0-point reduction in depression scores among 12 patients after treatment, with overall good tolerability.

AI Assistant

ATAI BECKLEY NV

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.